麻豆AV出品在线观看_偷偷鲁视频成人免费视频_乱子伦在线观看中文字幕_人碰人摸人爱免费视频在线观看

Search for the keyword:
   
Rabeprazole sodium azole pharmacokinetic
source:Vitalpharms Company Ltd.    Release date:2017-12-6 13:28:57

For ray Bella pharmacokinetics of sodium piece is? Below by guangdong rabeprazole azole sodium professionals to introduce:

1. The blood drug concentration

In healthy adult male in the case on an empty stomach or after meal oral dose of 20 mg, in all the time average drug concentration in plasma dynamic as shown. In addition, medicine and after meals on an empty stomach, the subjects of pharmacokinetic parameters of average value as shown in table. Compared with hollow when taking medicine, take medicine after dinner at the peak time (tmax) delayed 1.7 hours. At the same time, absorb the individual differences are very obvious.

In addition, the healthy adult male in fasting condition order oral 10 mg, 20 mg of pharmacokinetic parameters as shown below.

2. The urine excretion

Six healthy adult male oral medicine 20 mg, urine within 72 hours after the treatment did not check out the prototype drug, metabolites carboxylic acid body and glucuronic acid combination by urinary excretion accounted for about 30% of the dosage.

If you need to rabeprazole azole sodium this medicine, you can contact us rabeprazole azole sodium manufacturers, we will arrange for you!

Previous:Omeprazole micro pill effect/
Next:Candesartan ester serious adverse effects

About Us
Company Profile
Culture
Qualification
Staff style
Organization
News
Company News
Industry news
Media coverage
Products
Agent Products
Intermediates
Associated with the review and intermediates
Animal health related products
Merchants joined
Industry Standard
Quality certification
Contact Us
Vitalpharms Company Ltd.
Add.: 2/F, 3# Buliding, 169 Shihua Rd. West, Zhuhai, Guangdong, China.
Tel: +86-756-3326819/ 3221531
Fax: +86-756-3326816
E-MAIL: sales@www.palmbeachunited.com
Copyright©Vitalpharms Company Ltd.  Internet Drug Information Service Qualification Certificate: (Guangdong)- Non-operational -2023-0028   粵ICP備10097759號